Peel Hunt Reaffirms Hold Rating for Circassia Pharmaceuticals (CIR)

Peel Hunt restated their hold rating on shares of Circassia Pharmaceuticals (LON:CIR) in a report issued on Wednesday morning.

Shares of LON CIR opened at GBX 90.80 ($1.27) on Wednesday. Circassia Pharmaceuticals has a 12-month low of GBX 76.75 ($1.08) and a 12-month high of GBX 115.61 ($1.62).

COPYRIGHT VIOLATION WARNING: “Peel Hunt Reaffirms Hold Rating for Circassia Pharmaceuticals (CIR)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3340322/peel-hunt-reaffirms-hold-rating-for-circassia-pharmaceuticals-cir.html.

About Circassia Pharmaceuticals

Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates.

Receive News & Ratings for Circassia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Circassia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

J.Jill  Downgraded by ValuEngine
J.Jill Downgraded by ValuEngine
Neurometrix  Rating Lowered to Hold at ValuEngine
Neurometrix Rating Lowered to Hold at ValuEngine
Bell Canada  Hits New 1-Year High and Low at $42.00
Bell Canada Hits New 1-Year High and Low at $42.00
Building Materials  Hits New 52-Week High and Low at $18.00
Building Materials Hits New 52-Week High and Low at $18.00
LTC Properties  Reaches New 1-Year High and Low at $36.05
LTC Properties Reaches New 1-Year High and Low at $36.05
Analysts Set Sarepta Therapeutics Inc  PT at $80.47
Analysts Set Sarepta Therapeutics Inc PT at $80.47


Leave a Reply

© 2006-2018 Ticker Report. Google+.